What is Apella?
Founded in 2019, Apella is at the forefront of revolutionizing surgical procedures by leveraging artificial intelligence, computer vision, and advanced communication technologies. The company's innovative platform provides essential systematic quality control and data collection tools, aiming to improve the overall efficiency and outcomes for every member of the surgical team, from administrative staff to surgeons and, most importantly, patients. Apella's commitment to improving critical aspects of healthcare positions it as a key player in the medtech industry.
How much funding has Apella raised?
Apella has raised a total of $101M across 2 funding rounds:
Series A
$21M
Series B
$80M
Series A (2021): $21M with participation from Twine Ventures, PFM Health Sciences, Casdin Capital, and Vensana Capital Management
Series B (2026): $80M led by Operator Partners, Upside Partnership, OpAmp Capital, Vensana Capital Management, Houston Methodist, Casdin Capital, and PFM Health Sciences
Key Investors in Apella
Operator Partners
Operator Partners is a venture capital firm that invests its own capital in technology companies from Pre-Seed to Series B stages, focusing on partnering with founders to help them succeed without taking board seats or leading funding rounds.
Upside Partnership
Upside Partnership is a seed and pre-seed venture capital firm that focuses on investing in early-stage companies led by inevitable Founders, providing financial support and mentorship.
OpAmp Capital
Founded in 2022, OpAmp Capital is an early-stage VC firm specializing in deep tech and space technologies, offering founders support in recruiting, fundraising, and operations.
What's next for Apella?
With its recent major strategic investment, Apella is poised for accelerated growth and further development of its AI-driven surgical solutions. This latest round of financing, following previous capital infusions, indicates strong investor confidence in Apella's mission to enhance surgical quality and efficiency. The company is likely to focus on expanding its technological capabilities, scaling its operations, and deepening its market penetration within hospitals and surgical centers. Future strategic initiatives may involve further integration of its technology into existing healthcare workflows and exploring new applications for its AI and computer vision expertise in the broader medical field.
See full Apella company page
